Secondary Prevention of cardiovascular Events

被引：0
|
作者：
Mouret, P. [1 ]
机构：
[1] Sana Klinikum Offenbach, Chirurg Klin 2, Starkenburgring 66, D-63069 Offenbach, Germany
来源：
ORTHOPADE | 2019年 / 48卷 / 01期
关键词：
D O I：
10.1007/s00132-018-03661-x
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [31] Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome
    Vijayapraveena Paruchuri
    Juan Gaztanaga
    Vikash Rambhujun
    Robin Smith
    Michael E. Farkouh
    Cardiovascular Drugs and Therapy, 2018, 32 : 611 - 616
  • [32] AN EVALUATION OF SULOCTIDIL IN THE SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS SURVIVING A THROMBOEMBOLIC STROKE
    GENT, M
    STROKE, 1984, 15 (01) : 197 - 197
  • [33] Secondary prevention of cardiovascular events: is an educational intervention helpful? A randomized clinical trial
    Alcantara Reyes, J. M. A. R. Jose Maria
    Molina Ruiz, F. M. R. Flora
    Ariza Canete, J. A. C. Javier
    Navarro Luque, G. N. L. Gloria
    Martinez Zafra, R. M. Z. Rosa
    Garcia Gamez, M. G. G. Magdalena
    Villen Estevez, R. V. E. Rosario
    Mora Hidalgo, F. M. H. Francisco
    Linares Ortiz, S. L. O. Sofia
    Esteban Martinez, F. E. M. Fatima
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2013, 12 : S39 - S39
  • [34] Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)
    Pilz, Heidemarie
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2005, 155 (17-18) : 397 - 403
  • [35] Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events
    Bliden, Kevin P.
    Tantry, Udaya S.
    Chaudhary, Rahul
    Byun, Seunghwan
    Gurbel, Paul A.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (07) : 779 - 791
  • [36] Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiency
    Tonelli, M
    Collins, D
    Robins, S
    Bloomfield, H
    Curhan, GC
    KIDNEY INTERNATIONAL, 2004, 66 (03) : 1123 - 1130
  • [37] Atorvastatin - A pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events
    Plosker, Greg L.
    Lyseng-Williamson, Katherine A.
    PHARMACOECONOMICS, 2007, 25 (12) : 1031 - 1053
  • [38] Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency
    Tonelli, M
    Moyé, L
    Sacks, FM
    Kiberd, B
    Curhan, G
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (02) : 98 - 104
  • [39] Atherosclerosis and hormone replacement therapy: The role of estrogen in secondary prevention of cardiovascular events
    Sullivan, JM
    HORMONAL CARCINOGENESIS III, 2001, : 372 - 382
  • [40] Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome
    Paruchuri, Vijayapraveena
    Gaztanaga, Juan
    Rambhujun, Vikash
    Smith, Robin
    Farkouh, Michael E.
    CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (06) : 611 - 616
12345